We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.10% | 1,992.00 | 1,992.00 | 1,994.00 | 2,004.00 | 1,985.00 | 1,991.00 | 10,637 | 08:48:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 23.01 | 4.42B |
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 7 March 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 25 February 2022 under the 2014 Executive Incentive Plan ("EIP") Element B and 25 February 2021 under the EIP Element C.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Bassam Kanaan
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
a) |
Name |
Bassam Kanaan |
|
2 |
Reason for the notification |
||
a) |
Position/status |
PDMR |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained. |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
Nil |
EIP Award, Element B: 20,588 |
||
Nil |
EIP Award, Element C: 13,378 |
||
d) |
Aggregated information |
Price(s): nil Volume(s): 33,966 |
|
e) |
Date of the transaction |
6 March 2024 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Julie Hill
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
a) |
Name |
Julie Hill |
|
2 |
Reason for the notification |
||
a) |
Position/status |
PDMR |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards under the EIP Element B. |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
Nil |
5,339 |
||
d) |
Aggregated information |
Price(s): nil Volume(s): 5,339
|
|
e) |
Date of the transaction |
6 March 2024 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction |
Shares sold to cover tax following the vesting of conditional awards under the EIP Element B. |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
£19.275 |
2,190 |
||
d) |
Aggregated information |
Price(s): £19.275 Volume(s): 2,190 Total(s): £42,211.36
|
|
e) |
Date of the transaction |
6 March 2024 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Helen Middlemist
Group Company Secretary
+44 (0)20 7399 2760
7 March 2024
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions